| Duvic M, Talpur R
Optimizing denileukin diftitox (Ontak) therapy. [Journal Article, Research Support, Non-U.S. Gov't]
Future Oncol 2008 Aug; 4(4):457-69.
Abstract | Full Citation | Find Related Articles |
| Jiang Q, Zhang L, Wang R, et al.
FoxP3+CD4+ Treg cells play an important role in acute HIV-1 infection in humanized rag2-/-{gamma}C-/- mice in vivo. [JOURNAL ARTICLE]
Blood 2008 Jun 10.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Morse MA, Hobeika AC, Osada T, et al.
Depletion of human regulatory T cells specifically enhances antigen specific immune responses to cancer vaccines. [JOURNAL ARTICLE]
Blood 2008 Jun 2.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Ho VT, Cutler C
Current and novel therapies in acute GVHD. [Journal Article]
Best Pract Res Clin Haematol 2008 Jun; 21(2):223-37.
Abstract | Full Citation | Find Related Articles |
| Vidulich K, Jones D, Duvic M
Cutaneous gamma/delta T-Cell Lymphoma Treated with Radiation and Denileukin Diftitox. [Journal Article]
Clin Lymphoma Myeloma 2008 Feb; 8(1):55-8.
Abstract | Full Citation | Find Related Articles |
| Dean-Colomb W, Esteva FJ
Emerging agents in the treatment of anthracycline- and taxane-refractory metastatic breast cancer. [Journal Article]
Semin Oncol 2008 Apr; 35(2 Suppl 2):S31-8; quiz S40.
Abstract | Full Citation | Find Related Articles |
| Chen AI, Advani RH
Beyond the guidelines in the treatment of peripheral T-cell lymphoma: new drug development. [Journal Article]
J Natl Compr Canc Netw 2008 Apr; 6(4):428-35.
Abstract | Full Citation | Find Related Articles |
| Assaf C
Denileukin diftitox therapy for patients with tumour-stage mycosis fungoides. [Journal Article]
Dermatol Clin 2008 Jan.:21-2.
Full Citation | Find Related Articles |
| Wong BY, Ma Y, Fitzwilson R, et al.
De novo maintenance therapy with denileukin diftitox (Ontak(R)) in a patient with peripheral T-cell lymphoma is associated with prolonged remission. [JOURNAL ARTICLE]
Am J Hematol 2008 Feb 13.
Abstract | Full Citation |
| Robak T
Novel monoclonal antibodies for the treatment of chronic lymphocytic leukemia. [Journal Article, Research Support, Non-U.S. Gov't]
Curr Cancer Drug Targets 2008 Mar; 8(2):156-71.
Abstract | Full Citation |
  |
